Pinar Kanlikilicer
Pinar Kanlikilicer
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,
Recep Bayraktar
Recep Bayraktar
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Merve Denizli
Merve Denizli
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Mohammed H Rashed
Mohammed H Rashed
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Cristina Ivan
Cristina Ivan
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
dDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
b,d,
Burcu Aslan
Burcu Aslan
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,
Rahul Mitra
Rahul Mitra
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
b,
Kubra Karagoz
Kubra Karagoz
eRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
e,
Emine Bayraktar
Emine Bayraktar
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Xinna Zhang
Xinna Zhang
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
dDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
b,d,
Cristian Rodriguez-Aguayo
Cristian Rodriguez-Aguayo
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,
Amr Ahmed El-Arabey
Amr Ahmed El-Arabey
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
gPharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
a,g,
Nermin Kahraman
Nermin Kahraman
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Seyda Baydogan
Seyda Baydogan
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
a,
Ozgur Ozkayar
Ozgur Ozkayar
fHacettepe University, Ankara, Turkey
f,
Michael L Gatza
Michael L Gatza
eRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
e,
Bulent Ozpolat
Bulent Ozpolat
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,
George A Calin
George A Calin
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
cDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,c,
Anil K Sood
Anil K Sood
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
cDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
dDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
b,c,d,
Gabriel Lopez-Berestein
Gabriel Lopez-Berestein
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
cDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
a,b,c,⁎
aDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA
bCenter for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
cDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
dDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
eRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
fHacettepe University, Ankara, Turkey
gPharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
⁎Corresponding author at: Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit 1950, Houston, TX 77030, USA. glopez@mdanderson.org
Collection date 2020 Feb.
© 2020 Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
